van Es Charles 4

4 · Vita Coco Company, Inc. · Filed Apr 2, 2026

AI-generated summary of this filing

Updated Apr 2, 2026

Vita Coco (COCO) CCO Charles van Es Sells 2,000 Shares

What Happened

Charles van Es, Chief Commercial Officer of Vita Coco Company, sold 2,000 shares of common stock in an open-market transaction on April 1, 2026, at $48.67 per share for total proceeds of $97,340. This was a sale (not a purchase) and was effected pursuant to a Rule 10b5-1 trading plan, indicating pre-planned disposition.

Key Details

Transaction date and price: April 1, 2026 — 2,000 shares sold at $48.67 each (total $97,340).
Transaction code: S (Sale).
Method: Open market sale pursuant to a Rule 10b5-1 trading plan (Footnote F1).
Shares owned after transaction: Not specified in the provided filing.
Filing timeliness: Report filed April 2, 2026 for a 4/1/2026 transaction — appears timely (no late filing indicated).
Other footnotes in the filing relate to various option grants and vesting schedules (F2–F8) but are not described as directly connected to this specific sale.

Context

A sale under a 10b5-1 plan is typically a prearranged, rule-compliant disposition and does not necessarily reflect the insider’s current view of the company. Sales are common for liquidity/tax planning; purchases tend to be more informative about insider sentiment.

Form 4

Period: 2026-04-01

Chief Commercial Officer

Transactions

Holdings

Non-Qualified Stock Option (Right to Buy)
[F2]
Exercise: $10.18Exp: 2030-02-10→ Common Stock (53,750 underlying)
53,750
Non-Qualified Stock Option (Right to Buy)
[F2]
Exercise: $10.18Exp: 2031-01-11→ Common Stock (27,300 underlying)
27,300
Non-Qualified Stock Option (Right to Buy)
[F3]
Exercise: $15.00Exp: 2031-10-21→ Common Stock (58,043 underlying)
58,043
Non-Qualified Stock Option (Right to Buy)
[F4]
Exercise: $15.36Exp: 2032-08-15→ Common Stock (42,980 underlying)
42,980
Non-Qualified Stock Option (Right to Buy)
[F5]
Exercise: $16.91Exp: 2033-03-10→ Common Stock (14,025 underlying)
14,025
Non-Qualified Stock Option (Right to Buy)
[F6]
Exercise: $16.91Exp: 2033-03-10→ Common Stock (14,205 underlying)
14,205
Non-Qualified Stock Option (Right to Buy)
[F7]
Exercise: $26.18Exp: 2034-03-04→ Common Stock (8,746 underlying)
8,746
Non-Qualified Stock Option (Right to Buy)
[F8]
Exercise: $33.36Exp: 2035-03-04→ Common Stock (13,218 underlying)
13,218

Footnotes (8)

[F1]The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
[F2]The stock option is fully vested and currently exercisable.
[F3]The stock option vests in four equal annual installments beginning on November 27, 2022.
[F4]The stock option vests in three equal annual installments beginning on August 15, 2025.
[F5]The stock option is eligible to vest if certain performance conditions are met by the target date for the applicable performance condition(s) and expire if the performance conditions are not met by the final target date. The performance conditions applicable were timely satisfied, resulting in vesting of the option as to 14,025 shares on February 20, 2026.
[F6]The stock options vest in four annual equal installments beginning on March 10, 2024.
[F7]The stock option vests in four equal annual installments beginning on March 4, 2025.
[F8]The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.

Signature

/s/ Alison Klein, attorney-in-fact for Charles van Es|2026-04-02

1 file